Phio Pharmaceuticals Corp. (PHIO)
1.09
-0.04
(-3.54%)
USD |
NASDAQ |
Sep 03, 16:00
1.10
+0.01
(+0.92%)
After-Hours: 20:00
Phio Pharmaceuticals Cash from Operations (Annual) : -7.979M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -7.979M |
| December 31, 2024 | -7.112M |
| December 31, 2023 | -10.75M |
| December 31, 2022 | -12.13M |
| December 31, 2021 | -11.86M |
| December 31, 2020 | -8.802M |
| December 31, 2019 | -8.645M |
| Date | Value |
|---|---|
| December 31, 2018 | -7.52M |
| December 31, 2017 | -9.514M |
| December 31, 2016 | -7.76M |
| December 31, 2015 | -7.317M |
| December 31, 2014 | -7.758M |
| December 31, 2013 | -6.311M |
| December 31, 2012 | -5.062M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Imunon, Inc. | -13.90M |
| Agenus, Inc. | -77.20M |
| Amgen, Inc. | 9.958B |
| Anika Therapeutics, Inc. | 11.19M |
| BioCryst Pharmaceuticals, Inc. | 329.88M |